Overview
A food allergy is a hypersensitivity disorder in which the immune system mistakenly identifies a harmless food protein as a threat and mounts an IgE‑mediated response. This reaction typically occurs within minutes to a few hours after ingestion, although delayed non‑IgE mechanisms also exist. Common symptoms include oral itching, hives, swelling of the lips or tongue, gastrointestinal upset, wheezing, and in severe cases, anaphylaxis, a rapid systemic reaction that can compromise breathing and circulation.The prevalence of food allergies has risen dramatically over the past few decades, affecting an estimated 8 % of children and 5 % of adults worldwide. The most frequent allergens—often called the “big 8”—are milk, eggs, peanuts, tree nuts, soy, wheat, fish, and shellfish. Diagnosis relies on a combination of detailed clinical history, skin‑prick testing, serum specific IgE measurement, and, when necessary, supervised oral food challenges. Management centers on strict avoidance of the trigger, emergency preparedness with epinephrine auto‑injectors, and, increasingly, emerging therapies such as oral immunotherapy (OIT) and biologics.
Because food allergies can mimic other conditions and may evolve over time, individuals who suspect an allergy should seek evaluation by an allergist or qualified health professional. Prompt medical attention is essential if symptoms progress to difficulty breathing, throat tightness, or a drop in blood pressure, as these signs indicate anaphylaxis and require immediate epinephrine administration and emergency care.
History/Background
The concept of food‑induced allergic reactions dates back to ancient texts, but systematic scientific description began in the early 20th century. In 1906, Dr. Clemens von Pirquet coined the term “allergy” after observing hypersensitivity to substances, including foods. The first documented case of peanut allergy was reported in 1921, and the “big 8” allergens were identified through epidemiologic surveys in the 1970s and 1980s.A pivotal moment occurred in 1990 when the U.S. Food Allergen Labeling and Consumer Protection Act (FALCPA) mandated clear labeling of the major allergens, dramatically improving safety for consumers. The 2000s saw the rise of oral immunotherapy trials, and in 2017 the FDA approved the first epinephrine auto‑injector specifically designed for pediatric dosing. More recently, monoclonal antibodies such as omalizumab have been investigated to reduce reaction severity, marking a shift toward targeted immunomodulation.
Key Information
- Immunologic Mechanism: Most food allergies are IgE‑mediated, involving mast cell degranulation and release of histamine, leukotrienes, and prostaglandins. Non‑IgE pathways (e.g., T‑cell mediated) can cause delayed eczema or gastrointestinal symptoms. - Common Triggers: Milk, eggs, peanuts, tree nuts, soy, wheat, fish, and shellfish account for roughly 90 % of reactions in Western countries. Regional variations exist; for example, rice and chickpea are notable allergens in parts of Asia. - Diagnosis: 1. Detailed exposure and symptom history. 2. Skin‑prick test (SPT) – rapid, high sensitivity. 3. Serum specific IgE – useful when skin testing is contraindicated. 4. Oral food challenge (OFC) – gold standard, performed under medical supervision. - Management: - Avoidance – reading labels, cross‑contamination prevention, and education. - Emergency plan – carrying two epinephrine auto‑injectors, training caregivers, and wearing medical alert identification. - Therapeutic advances – OIT, epicutaneous immunotherapy (EPIT), and biologics (e.g., anti‑IgE, anti‑IL‑4Rα) are expanding options for desensitization. - Prognosis: Many children outgrow allergies to milk, egg, wheat, and soy, often by age 5–7. Peanut, tree nut, fish, and shellfish allergies tend to persist into adulthood, though recent OIT studies suggest possible long‑term tolerance in a subset of patients.Significance
Food allergies represent a major public health concern due to their potential for rapid, severe reactions and the pervasive presence of allergens in modern food systems. They affect quality of life, leading to anxiety, social restrictions, and increased health‑care utilization. Schools, airlines, and restaurants have adopted policies—such as allergen‑free zones and staff training—to mitigate risk. Economically, the burden includes direct medical costs (emergency visits, prescriptions) and indirect costs (missed work, special dietary needs).Research into the microbiome, genetic predisposition, and environmental exposures is reshaping our understanding of why allergy rates have surged, informing preventive strategies like early introduction of allergenic foods (e.g., the LEAP study for peanuts). Moreover, the development of precision therapies promises to move beyond avoidance toward true disease modification, potentially reducing the lifelong impact of food allergies for future generations.
